Connecting kidney-disease biology with biomarkers that may improve how kidney injury and transplant health are assessed.
Currently: Translational nephrology researcher · Department of Critical Care Medicine, Medanta Hospital, Ranchi, India (ongoing study collaboration) · Research collaborator, International Renal Research Institute of Vicenza (IRRIV), Italy.
A visual overview of the translational pathway connecting kidney transplantation, extracellular-vesicle phenotyping, biomarker integration, and regenerative nephrology.
My work bridges clinical nephrology and translational biomarker science. I have experience in urinary and plasma extracellular-vesicle isolation, MACSPlex multiplex bead-based flow-cytometric phenotyping, prospective human cohorts, clinical biomarker studies, cell and tissue culture, regenerative medicine and multicentre research, with international experience across Italy, Denmark and India.
A focused portfolio around kidney transplantation, extracellular-vesicle biology and clinically actionable biomarker translation.
Renal allograft injury, donor/recipient phenotyping, rejection biology and multimarker monitoring strategies.
TransplantationUrinary and plasma EV isolation, multiplex flow-cytometric phenotyping and translational interpretation.
EV biologyBiomarker-validation frameworks, clinical-molecular data integration and precision phenotyping in kidney disease.
BiomarkersMechanism-informed phenotyping, evidence synthesis and clinically oriented precision kidney medicine.
CKDAKI biomarkers, sepsis-associated kidney dysfunction and renal-support research.
AKI / CRRTCell and tissue culture, regenerative medicine concepts and kidney-repair biology within translational nephrology research.
RegenerationUrinary and plasma EV isolation, pre-analytical handling and translational phenotyping workflows.
EV workflowsMultiplex bead-based EV phenotyping, flow-cytometric acquisition and interpretation in biomarker studies.
Flow cytometryHands-on cell and tissue culture experience supporting translational, regenerative and kidney-disease research.
Cell cultureRegenerative medicine approaches, kidney repair biology and translational framing of cell-based and tissue-level research.
Regenerative nephrologyClinical biomarker framing, multimarker strategies, sample-linked phenotyping and interpretation.
Translational biomarkersProspective human studies, biospecimen-linked research, protocol/CRF development, multicentre coordination, data-quality review and trial-related study documentation.
Clinical researchStudy protocols, case-report forms, research documentation and operational study planning.
Study designEvidence synthesis, manuscript development, translational project framing and publication-oriented reporting.
Scientific writingHuman urine and plasma sample handling, pre-analytical preparation and biomarker-oriented study workflows.
Human biospecimensInternational research experience spanning academic nephrology, kidney transplantation, critical care and translational laboratory science.
Protocol and case-report-form (CRF) development, prospective data collection, data-quality review, and planned multicentre analysis and reporting. Study collaboration rather than a salaried hospital appointment.
Longitudinal urinary and plasma extracellular-vesicle profiling in kidney-transplant recipients.
Renal functional reserve and urinary extracellular-vesicle phenotyping in living kidney donors.
Research Fellow, 2018. Research fellowship in critical-care nephrology.
Research Collaborator, 2018–Present. Ongoing joint work with Prof. Claudio Ronco on AKI biomarkers, continuous renal replacement therapy (CRRT), sepsis-associated kidney injury, and scientific publications.
Kidney transplantation, donor-specific antibodies, biomarkers, regenerative medicine and clinical research.
University of Turin · PhD in Medical Physiopathology · 2018–2022. Doctoral research integrated renal functional reserve testing with longitudinal urinary extracellular-vesicle phenotyping in living kidney donors before and after nephrectomy.
17 scholarly publications: 16 peer-reviewed articles and 1 book chapter, including 11 PubMed-indexed publications. Selected work is shown below.
Digvijay K, Birn H, Ronco C · Medicina 62(10):1878
Digvijay K, Birn H · Medicina 62(4):664 · PMID: 42075536
Digvijay K et al. · Kidney and Dialysis 3(3):255–264
Bhargava V et al., including Digvijay K · Indian Journal of Nephrology 31(4):370–376 · PMID: 34584353
Xie Y et al., including Digvijay K · Kidney International 95(6):1486–1493 · PMID: 30982674
Digvijay K, Neri M, Fan W, Ricci Z, Ronco C · Blood Purification · PMID: 30269144
Selected manuscripts are listed separately from published research. Submission and review status may change; these items should not be cited as published papers.
Editorial appointments, peer review, society activity and scientific communication reflect broader contribution to the academic and nephrology community.
Pathophysiological Mechanisms and Therapeutic Strategies in Kidney Diseases.
2026–PresentKidney Transplantation Complications.
2024–2025Nephron, BMC Nephrology, Diagnostics, Cells, Paediatric Reports and related biomedical journals.
2019–PresentCurrent Medicine Research and Practice.
2020–PresentVolunteer scientific communication coordinator, Nephro Critical Care Society, India.
2026–PresentISN · ASN · ISEV · Alliance for Regenerative Medicine.
NetworkFor research collaboration, translational nephrology or biomarker consultation, scientific-writing support, academic opportunities or industry enquiries, use the private form below. Nephra can answer quick questions about my public professional profile.
This channel is for academic and clinical collaborations, translational nephrology or biomarker consultation, pharma/biotech/CRO/MedTech enquiries, scientific-writing support, study development and professional opportunities.
Professional email: contact@kumardigvijay.com
Brief feedback helps improve the clarity of this website and the usefulness of Nephra. This is separate from formal consultation and collaboration enquiries.
Share comments about website clarity, Nephra’s answers, missing information or content that could be easier to find. Feedback is received privately and is not published on the site.